Back

Simultaneous versus sequential initiation of CKM therapies: an indirect comparison of CONFIDENCE and FIDELITY

30 August 2026 (12:24 - 12:36)
Organised by: Logo
Congress Presentation Part of: Optimising pharmacotherapy in heart failure Aldosterone Antagonists ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Evaluation of machine learning framework for personalized prediction of benefit from beta-blockers in myocardial infarction with preserved or mildly reduced ejection fraction
Doctor Y. Chen (Beijing, CN)
Abstract
Presentation thumbnail
The LUNAR-HF Trial: a randomised comparison of inclisiran versus evolocumab in ischaemic heart failure with reduced ejection fraction
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract
Presentation thumbnail
Finerenone-related initial declines in eGFR and urinary biomarkers of tubular injury: mechanistic insights from the FIVE-STAR trial
Doctor M. Vaduganathan (Boston, US)
Abstract
Presentation thumbnail
Finerenone and serum sodium in patients with heart failure and mildly reduced or preserved ejection fraction: an analysis of FINEARTS-HF
Doctor R. Ono (Glasgow, GB)
Abstract

Access the full session

Session thumbnail
Optimising pharmacotherapy in heart failure

The Event

Event poster

ESC Congress 2026

30 August 2026 12:24 CET
You may be interested in
thumbnail
Congress Presentation
Effect of finerenone on morbidity and mortality in chronic kidney disease and type 2 diabetes: FINE-HEART analysis of 3 randomized clinical trials
19 May 2025
thumbnail
Congress Presentation
Eligibility for simultaneous initiation of the four pharmacological pillars of heart failure with reduced ejection fraction at discharge
21 May 2023
thumbnail
Congress Presentation
Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis
27 August 2021
thumbnail
Congress Presentation
CONFIDENCE: ambulatory blood pressure monitor substudy
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources